共 50 条
- [21] Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaBLOOD, 2021, 138Qin, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaHe, Xiaohui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaYang, Sheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaLiu, Peng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaZhou, Shengyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaYang, Jianliang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaGui, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaZhong, Qiaofeng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaZhao, Fengyi论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaJing, Hongmei论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Third Hosp, Dept Hematol, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaZhang, Shiyue论文数: 0 引用数: 0 h-index: 0机构: Shanghai Junshi Biosci, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaGuo, Ruihan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Junshi Biosci, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
- [22] Open-Label, Single-Arm, Phase II Study of Everolimus in Patients with Relapsed/Refractory Classical Hodgkin LymphomaBLOOD, 2011, 118 (21) : 1169 - 1169Johnston, Patrick B.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Mayo Clin, Rochester, MN USAPinter-Brown, Lauren论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA Mayo Clin, Rochester, MN USARogerio, Jaqueline论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Mayo Clin, Rochester, MN USAWarsi, Ghulam论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Mayo Clin, Rochester, MN USAGraham, Anne论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Mayo Clin, Rochester, MN USARamchandren, Radhakrishnan论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USA Mayo Clin, Rochester, MN USA
- [23] A Multicenter Open-Label, Phase 1b/2 Study of Ibrutinib in Combination with Lenalidomide and Rituximab in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)BLOOD, 2016, 128 (22)Goy, Andre论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USARamchandren, Radhakrishnan论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAGhosh, Nilanjan论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst Carolinas Healthcare Syst, Charlotte, NC USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAMunoz, Javier论文数: 0 引用数: 0 h-index: 0机构: Banner MD Anderson Canc Ctr, Gilbert, AZ USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAMorgan, David S.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USADang, Nam H.论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Gainesville, FL USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAKnapp, Mark论文数: 0 引用数: 0 h-index: 0机构: Mid Ohio Oncology Hematol Inc, Columbus, OH USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USADelioukina, Maria论文数: 0 引用数: 0 h-index: 0机构: Cedars Sinai Med Ctr, Los Angeles, CA USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAKingsley, Edwin C.论文数: 0 引用数: 0 h-index: 0机构: Comprehens Canc Ctrs Nevada, Las Vegas, NV USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAAnh Tran论文数: 0 引用数: 0 h-index: 0机构: AbbVie Co, Pharmacycl LLC, Sunnyvale, CA USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USAPing, Jerry论文数: 0 引用数: 0 h-index: 0机构: AbbVie Co, Pharmacycl LLC, Sunnyvale, CA USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USABeaupre, Darrin M.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Co, Pharmacycl LLC, Sunnyvale, CA USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USANeuenburg, Jutta K.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Co, Pharmacycl LLC, Sunnyvale, CA USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USARuan, Jia论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, New York, NY USA Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
- [24] An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphomaBLOOD, 2018, 132 (14) : 1486 - 1494Morschhauser, Franck论文数: 0 引用数: 0 h-index: 0机构: Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceSalles, Gilles论文数: 0 引用数: 0 h-index: 0机构: Univ Lyon, Ctr Hosp Lyon Sud, Hosp Civils Lyon, Hematol, Pierre Benite, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceLe Gouill, Steven论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Dept Haematol, Nantes, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceTilly, Herve论文数: 0 引用数: 0 h-index: 0机构: Univ Rouen, Ctr Henri Becquerel, Dept Hematol, U1245, Rouen, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceThieblemont, Catherine论文数: 0 引用数: 0 h-index: 0机构: Inst Univ Hematol, Hosp St Louis, AP HP, Hematooncol Dept,INSERM U728, Paris, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceBouabdallah, Krimo论文数: 0 引用数: 0 h-index: 0机构: CHU Bordeaux, Serv Hematol & Therapie Cellulaire, Bordeaux, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceFabiani, Bettina论文数: 0 引用数: 0 h-index: 0机构: Hop St Antoine, AP HP, Paris, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceMenard, Cedric论文数: 0 引用数: 0 h-index: 0机构: Univ Rennes, Unite Mixte Rech UMR S1236, Etab Francais Sang, INSERM, Rennes, France CHU Rennes, Suivi Immunol Therapeut Innovantes, Etab Francais Sang, Rennes, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, FranceTarte, Karin论文数: 0 引用数: 0 h-index: 0机构: Univ Rennes, Unite Mixte Rech UMR S1236, Etab Francais Sang, INSERM, Rennes, France CHU Rennes, Suivi Immunol Therapeut Innovantes, Etab Francais Sang, Rennes, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, France论文数: 引用数: h-index:机构:Houot, Roch论文数: 0 引用数: 0 h-index: 0机构: CHU Rennes, Haematol Dept, Rennes, France Univ Lille, CHRU Lille, Serv Malad Sang, Grp Rech Formes Injectables & Technol Associees, Lille, France
- [25] Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patientsEUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 356 - 364Qin, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaHe, Xiaohui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaChen, Xinrui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaXie, Zucheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaYang, Jianliang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaYang, Sheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaLiu, Peng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaZhou, Shengyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaZhang, Changgong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaGui, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol,Beijing Key, Beijing, Peoples R China
- [26] PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphomaANNALS OF HEMATOLOGY, 2023, 102 (08) : 2189 - 2198Ping, Liqin论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaGao, Yan论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaHe, Yanxia论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaBai, Bing论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaHuang, Cheng论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaShi, Lina论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaWang, Xiaoxiao论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaHuang, Huiqiang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
- [27] PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphomaAnnals of Hematology, 2023, 102 : 2189 - 2198Liqin Ping论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineYan Gao论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineYanxia He论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineBing Bai论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineCheng Huang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineLina Shi论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineXiaoxiao Wang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineHuiqiang Huang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
- [28] Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II studyANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (24)Chen, Xinrui论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Inst Translat Med, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaWang, Huaqing论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Inst Translat Med, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaSun, Xiuhua论文数: 0 引用数: 0 h-index: 0机构: Dalian Med Univ, Hosp 2, Dept Oncol, Dalian, Liaoning, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaSu, Liping论文数: 0 引用数: 0 h-index: 0机构: Shanxi Prov Canc Hosp, Dept Hematol, Taiyuan, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaLiu, Fengting论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Inst Translat Med, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaZhao, Ke论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Inst Translat Med, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaXu, Liye论文数: 0 引用数: 0 h-index: 0机构: Dalian Med Univ, Hosp 2, Dept Oncol, Dalian, Liaoning, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaWu, Shaohua论文数: 0 引用数: 0 h-index: 0机构: Shanxi Prov Canc Hosp, Dept Hematol, Taiyuan, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R ChinaSong, Teng论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Inst Translat Med, Tianjin, Peoples R China Nankai Univ, Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China
- [29] Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trialLANCET HAEMATOLOGY, 2018, 5 (03): : E109 - E116Jerkeman, Mats论文数: 0 引用数: 0 h-index: 0机构: Lund Univ, Inst Clin Sci, Dept Oncol, Lund, Sweden Skane Univ Hosp, Lund, Sweden Lund Univ, Inst Clin Sci, Dept Oncol, Lund, Sweden论文数: 引用数: h-index:机构:Hutchings, Martin论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, Dept Haematol, Copenhagen, Denmark Univ Copenhagen, Fac Hlth Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenRaty, Riikka论文数: 0 引用数: 0 h-index: 0机构: Helsinki Univ Hosp, Dept Haematol, Helsinki, Finland Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenWader, Karin Fahl论文数: 0 引用数: 0 h-index: 0机构: St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenLaurell, Anna论文数: 0 引用数: 0 h-index: 0机构: Akad Univ Hosp, Dept Oncol, Uppsala, Sweden Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenToldbod, Helle论文数: 0 引用数: 0 h-index: 0机构: Aarhus Univ Hosp, Clin Trial Off, Dept Haematol, Aarhus, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenPedersen, Lone Bredo论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, Dept Haematol, Copenhagen, Denmark Univ Copenhagen, Fac Hlth Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenNiemann, Carsten Utoft论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, Dept Haematol, Copenhagen, Denmark Univ Copenhagen, Fac Hlth Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenDahl, Christina论文数: 0 引用数: 0 h-index: 0机构: Danish Canc Soc, Res Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenKuitunen, Hanne论文数: 0 引用数: 0 h-index: 0机构: Oulu Univ Hosp, Dept Oncol, Oulu, Finland Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenGeisler, Christian H.论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, Dept Haematol, Copenhagen, Denmark Univ Copenhagen, Fac Hlth Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenGronbaek, Kirsten论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, Dept Haematol, Copenhagen, Denmark Univ Copenhagen, Fac Hlth Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark Lund Univ, Inst Clin Sci, Dept Oncol, Lund, SwedenKolstad, Arne论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Dept Oncol, Oslo, Norway Lund Univ, Inst Clin Sci, Dept Oncol, Lund, Sweden
- [30] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemiaPEDIATRIC BLOOD & CANCER, 2021, 68 (07)O'Brien, Maureen M.论文数: 0 引用数: 0 h-index: 0机构: Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAAlonzo, Todd A.论文数: 0 引用数: 0 h-index: 0机构: Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USACooper, Todd M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle Childrens Canc & Blood Disorders Ctr, Seattle, WA USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USALevine, John E.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Bone Marrow & Stem Cell Transplantat Program, New York, NY USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USABrown, Patrick A.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USASlone, Tamra论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAAugust, Keith J.论文数: 0 引用数: 0 h-index: 0机构: Childrens Mercy Hosp Kansas City, Kansas City, MO USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USABenettaib, Bouchra论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USABiserna, Noha论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAPoon, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAPatturajan, Meera论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAChen, Nianhang论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USASimcock, Mathew论文数: 0 引用数: 0 h-index: 0机构: Celgene Ltd, Uxbridge, Middx, England Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAZimmerman, Linda论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Overland Pk, KS USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USAKolb, E. Anders论文数: 0 引用数: 0 h-index: 0机构: Alfred I DuPont Hosp Children, Nemours Ctr Canc & Blood Disorders, Delaware, OH USA Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Coll Med, Cincinnati, OH USA